Prostate Cancer - Results from #26680

Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer - Abstract December 9, 2011

Cause-specific mortality following radical prostatectomy - Abstract December 9, 2011

Cost-effectiveness of Prostate Health Index for prostate cancer detection - Abstract December 8, 2011

Role and expression of FRS2 and FRS3 in prostate cancer - Abstract December 8, 2011

Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance - Abstract December 8, 2011

Surgical therapy for intermediate risk prostate cancer - Abstract December 8, 2011

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores - Abstract December 8, 2011

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer - Abstract December 8, 2011

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer - Abstract December 8, 2011

Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study - Abstract December 8, 2011

Expansion/de-expansion tool to quantify the accuracy of prostate contours - Abstract December 8, 2011

Identification of markers of prostate cancer progression using candidate gene expression - Abstract December 7, 2011

General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations - Abstract December 7, 2011

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies - Abstract December 7, 2011

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer - Abstract December 7, 2011

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer - Abstract December 7, 2011

Androgen deprivation and thromboembolic events in men with prostate cancer - Abstract December 6, 2011

Docetaxel-based chemotherapy for hormone-refractory prostate cancer in Japanese patients : Experience in a single institute - Abstract December 6, 2011

Bone mineral density, pathological fractures and bisphosphonate therapy in prostate cancer patients on androgen deprivation therapy - Abstract December 6, 2011

Lycopene for the prevention of prostate cancer - Abstract December 5, 2011

Page 1335 of 1437